Stockreport

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary [Yahoo! Finance]

L'OREAL UNSP/ADR  (LRLCY) 
NASDAQ:AMEX Investor Relations: loreal-finance.com/eng
PDF health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the execution of a definitive agreement to sell its wholly owned subsidiary, Axolotl Biologix (“ [Read more]